Of course, all this does not in any way absolve Sanofi Pasteur, one of the largest and best known manufacturers of pharmaceutical products, from responsibility and the crisis caused in the Philippines. Its negligence has caused untold misery to 730,000 people, mostly children, who were administered the suspect vaccine. They are likely to suffer for no fault on their part, or even any that of their government. That country launched a huge immunisation campaign that hinged on a vaccine from a top manufacturer and carried the stamp of WHO approval. Many children would die. No amount of compensation from Sanofi can make up for the grievous harm done to the unsuspecting people.
Only a total ban on Sanofi and summary dismissal of all those concerned with the matter at WHO might meet the demands of social justice. India can only take sadistic and morbid pleasure in having avoided an even bigger disaster because our people sat on the case and the “red tape” kept the files tied shut! Krishan Kalra Gurugram
Letters can be mailed, faxed or e-mailed to: The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg New Delhi 110 002
Fax: (011) 23720201 · E-mail: letters@bsmail.in
All letters must have a postal address and telephone number
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
